{"pub": "yahoo", "url": "https://finance.yahoo.com/news/medmen-falls-15-net-loss-155035914.html", "downloaded_at": "2019-10-30 09:56:51.517614+00:00", "title": "MedMen Falls 15% As Net Loss More Than Doubles", "language": "en", "text": "MedMen Enterprises Inc. (CSE: MMEN) (OTC: MMNFF) reported fourth-quarter revenue of $42 million on Monday, up by 104% year-over-year, and record full-year revenue of $130 million, up by 227% year-over-year.\n\nThe cannabis company posted a fourth-quarter net loss of $82.9 million.\n\nThe gross margin for retail operations in the quarter was 50%.\n\n2019 Results\n\nThe company's full-year adjusted EBITDA loss amounted to $172 million, more than triple the 2018 figure.\n\nMedMen's net loss was $277 million for 2019; $79.1 million, or 75 cents per share, was attributable to the company\u2019s shareholders, MedMen said.\n\nThe net loss in 2018 was $113.9 million.\n\n\u201cFiscal 2019 was a transformative year for MedMen, with over 2 million completed retail transactions to date and revenues increasing 227% year-over-year,\u201d Adam Bierman, MedMen's co-founder and CEO, said in a statement.\n\nView more earnings on MMNFF\n\n\u201cOur success was due, largely in part, to our loyal customer base. Throughout the year, we served over 1 million customers from all 50 states and more than 100 countries. In California, the largest cannabis market in the world, MedMen surpassed a record $110 million in annualized run-rate retail revenue.\u201d\n\nMedMen detailed business developments including the launch of its delivery service in California and Nevada, the start of its new loyalty program, MedMen Buds; its continued Florida expansion and the termination of its merger with PharmaCann.\n\nMedMen shares were down 17.27% at $1.15 at the time of publication.\n\nRelated Links:\n\nExclusive: MedMen CEO Talks Pharmacann M&A Termination, CFO Change\n\nMedMen Opens Three New Florida Retail Locations, Bringing National Footprint To 29 Stores\n\nPhoto courtesy of MedMen.\n\nSee more from Benzinga\n\n\u00a9 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.", "description": "MedMen's net loss was $277 million for 2019;\u00a0$79.1 million, or 75 cents per share, was attributable to the company\u2019s shareholders, MedMen said.  \u201cFiscal 2019 was a transformative year for MedMen, with over 2 million completed retail transactions to date and revenues increasing 227% year-over-year", "authors": ["Nina Zdinjak"], "top_image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo.png", "published_at": "2019-10-29"}